Ebola Stocks to Buy 2015 – Top Ebola Stocks 2015
Ebola Stocks 2015 – Ebola Stocks are colling down into 2015 after several people that were infected with the Ebola virus in the U.S were cured. Right now there is a huge epidemic going on in West Africa which is causing fear around the world. Since the Ebola disease is so rare, many companies haven’t been spending money on Ebola research which is causing a shortage in drugs. The 2014 Ebola stock surge was mainly in a few companies but they were red hot. Keep in mind, most of these Ebola companies are very risky and if the virus continues to become under control, they will see a large drop. Below is a list of the Ebola stocks to invest in if you are looking for the best ones.
Top Stocks 2015 – Click Here
Top Penny Stocks 2015 – Click Here
Today’s Biggest Gainers – Click Here
Best Ebola Stocks – Tekmira Pharmaceuticals (TKMR) is the Top Ebola Stock to Buy right now. If you are looking for a pure play Ebola Stock, Tekmira Pharmaceuticals (TKMR) is the Ebola Stock you want to invest in. Tekmira Pharmaceuticals (TKMR) is the Best Ebola Stock because the company is one of the only public ebola companies to have a drug in trials. TKM-Ebola was used to treat the third Ebola patient, Richard Sacra, at which he was then cured and released from the hospital. However, we can’t be sure if TKM-Ebola actually caused the virus to leave his body as he was receiving other treatments. TKM-Ebola attempts to stop the Ebola virus from replicating and so far it has shown promising results. While investing in Ebola stocks is very risky, TKMR is the Top Ebola Stock to Buy if you think Ebola will spiral out of control.
For many years, the Zaire species of Ebola virus (ZEBOV), a highly contagious and lethal human infectious disease, has been associated with periodic outbreaks of hemorrhagic fever in human populations with mortality rates reaching 90%.
In March 2014, TKMR was granted a Fast Track designation from the U.S. Food and Drug Administration (FDA) for the development of TKM-Ebola, our anti-Ebola viral RNAi therapeutic. The FDA’s Fast Track is a process designed to facilitate the development and expedite the review of drugs in order to get important new therapies to the patient earlier.
TKM-Ebola is being developed under specific FDA regulatory guidelines called the “Animal Rule.” The Animal Rule provides that under certain circumstances, where it is unethical or not feasible to conduct human efficacy studies, the FDA may grant marketing approval based on adequate and well-controlled animal studies when the results of those studies establish that the drug is reasonably likely to produce clinical benefit in humans. Demonstration of the product’s safety in humans is still required.
Top Ebola Stocks – Chimerex (CMRX) has a trial drug which is being tested in West Africa. Chimerix, Inc. (CMRX), a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, today announced that its investigational broad-spectrum antiviral brincidofovir has been selected as one of two investigational agents to be evaluated in a clinical study in patients with confirmed Ebola Virus Disease in west Africa. Chimerix and the University of Oxford are in the process of finalizing a definitive agreement for supplying brincidofovir for the planned clinical trial.
Other Ebola Stocks to Buy – Below is a list of additional Ebola stocks to watch in 2015
GlaxoSmithKline (GSK) – GlaxoSmithKline (GSK) is currently in the early stages of an Ebola Vaccine which will prevent you from getting the disease.
Lakeland Industries Inc. (LAKE) – Lakeland Industries Inc. (LAKE) sells safety Hazmat suits and is seeing an increase in orders.
BioCryst Pharmaceuticals, Inc. (BCRX)
Sarepta Therapeutics, Inc. (SRPT)
NewLink Genetics Corporation (NLNK)
Inovio Pharmaceuticals, Inc. (INO)
Ebola Penny Stocks – Hemispherx Biopharma, Inc. (HEB) is an Ebola Penny Stock that recently announced they will be attempting to start a drug trial.